99% Savings - Buy Just @1 Rs X
Signoflam Tablet is a prescription drug, available for use as Tablet. Other than this, Signoflam Tablet has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Signoflam Tablet depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Signoflam Tablet also has some side effects, the most common being Nausea or vomiting, Diarrhoea, Dizziness. Usually, these side effects of Signoflam Tablet go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Signoflam Tablet has a Severe effect for pregnant women and Severe effect on lactating mothers. Warnings related to Signoflam Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Signoflam Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Signoflam Tablet in conditions like Kidney Disease, Asthma, Heart Attack.
Additionally, Signoflam Tablet may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Signoflam Tablet is not safe while driving, and is is not addictive in nature.
Signoflam Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Signoflam Tablet safe for pregnant women?
Signoflam Tablet should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Signoflam Tablet safe during breastfeeding?
Signoflam Tablet may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Signoflam Tablet on the Kidneys?
Kidney can be affected by Signoflam Tablet. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Signoflam Tablet on the Liver?
You may experience side effects on your liver after taking Signoflam Tablet. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Signoflam Tablet on the Heart?
Signoflam Tablet can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Signoflam Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Signoflam Tablet unless your doctor advises you to do so -
Is this Signoflam Tablet habit forming or addictive?
No, there is no any evidence that Signoflam Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Signoflam Tablet, you should not drive or work on any heavy machine, as Signoflam Tablet can make you drowsy.
Is it safe?
Yes, but take Signoflam Tablet only as per medical advice.
Is it able to treat mental disorders?
No, Signoflam Tablet is not used to treat mental disorders.
Interaction between Food and Signoflam Tablet
Due to the absence of research, it is difficult to say how Signoflam Tablet and food will interact.
Interaction between Alcohol and Signoflam Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Signoflam Tablet with alcohol will be.
Signoflam Tablet is a brand name for aceclofenac. It is a prescription drug that belongs to the class of medications called NSAIDs (Nonsteroidal anti-inflammatory drug). It is mainly used to relieve pain in a patient's suffering from rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. Additionally, it also reduces fever.
Yes, Signoflam Tablet can be taken for relieving symptoms of a headache. However, there are better medicines available for treating headache effectively.
Signoflam Tablet preferably taken with a light meal. It can be taken once or twice a day or more as your doctor has prescribed it.
No, Signoflam Tablet is not used for treating stomach pain. The stomach pain could be due to some underlying medical condition which may require medical attention. If the pain does not subside within 1 day. Please consult your doctor without any further delay.
Signoflam Tablet is a pain relieving medicine. One should take as long as he/she has been recommended to take. However, sometimes even after symptomatic relief your doctor may ask you to continue with medication to reduce inflammations in the body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206-207
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Acetaminophen (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ofirmev (acetaminophen)
Package Leaflet Information For The User [Internet]: Aceclofenac 100 mg film-coated Tablets. Accord Healthcare Limited
Package leaflet Information for the patient [Internet]: Paracetamol Tablets 500mg. actavis
Shivani Bhagat*, Monika Agarwal, Vandana Roy [Internet]: Serratiopeptidase: A systematic review of the existing evidence. International Journal of Surgery 11 (2013) 209e217